[Susceptibility and the immune response to Trichinella spiralis infection] NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Susceptibility and the immune response to Trichinella spiralis infection]

Glas Srp Akad Nauka [Med]. 1992;(42):83-91. Unique Identifier : AIDSLINE MED/94040967
Bugarski D; Sofronic-Milosavljevic Lj; Movsesijan M; Cuperlovic K; Institute of the Application of Nuclear Energy, Zemum.

Abstract: The aim of this study was to assess a possible association between parameters of immune response and susceptibility/resistance to T. spiralis infection. The immune response to T. spiralis was monitored in two inbred strains of mice (BALB/c and C57Bl/6), as well as in the most important natural host--swine, by analysing the changes in main lymphocyte populations, the appearance of specific antibodies and worm burden recovery. In the murine model, the lower level of muscle larvae worm burden recovery in mice expressed greater resistance (BALB/c) was associated with manifested clinical signs, earlier development of humoral antibody response and a persistently higher level of CD4/CD8 T cell ratio, compared to T. spiralis-susceptible mice (C57Bl/6). In swine, high susceptibility to infection was also associated with lack of clinical symptoms, a delayed development of an antibody response and persistently low CD4/CD8 T cell ratio.
Keywords: Animal Antibodies, Helminth/BIOSYNTHESIS CD4-CD8 Ratio Disease Susceptibility English Abstract Lymphocytes/IMMUNOLOGY Male Mice Mice, Inbred BALB C Mice, Inbred C57BL Swine *Trichinella spiralis/IMMUNOLOGY Trichinosis/*IMMUNOLOGY JOURNAL ARTICLEKWDanimalantibodies,helminth/biosynthesiscd4-cd8ratiodiseasesusceptibilityenglishabstractlymphocytes/immunologymalemicemice,inbredbalbcmice,inbredc57blswineKWDtrichinellaspiralis/immunologytrichinosis/KWDimmunologyjournalarticle
940228
M9420808

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .